AbbVie's stock is now dirt cheap.
News & Analysis: AbbVie
This pharma stock should be a solid pick for income-seeking investors.
Now's the time to add these companies to your portfolio.
Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
The time is now to lock in attractive dividend yields with these three stocks.
Thanks to the recent stock market correction, these two pharma giants are excellent bargain buys.
Bargain prices and tremendous growth prospects make these stocks really attractive.
As a Magic 8-ball might say, "Signs point to yes."
The coronavirus outbreak has made shares of top drugmakers more attractive than they've been in a quite a while.
Should investors pick safety over growth?